| 中文名稱:AZD3965 | 英文名稱:AZD3965 |
| CAS:1448671-31-5 | 品牌: 阿拉丁 |
| 產(chǎn)地: 上海 | 保存條件: -20°C儲存 |
| 純度規(guī)格: Moligand?, ≥98% | 產(chǎn)品類別: 小分子和化合物庫 |
| 分子式: C21H24F3N5O5S | 分子量: 515.51 |
| 運輸條件: 超低溫運輸 | 產(chǎn)品規(guī)格: 5mg、100mg、10mg |
| 貨號: A413743 | 是否進口: 否 |
中文名:AZD3965
英文名:AZD3965
純度:Moligand?,≥98%
貨號:A413743
Cas號:1448671-31-5
存儲溫度:-20°C儲存
運輸條件:超低溫運輸
產(chǎn)品介紹:
Information
AZD3965 AZD3965 is a potent, selective and orally available monocarboxylate transporter 1 ( MCT1 ) inhibitor with a binding affinity of 1.6 nM, 6-fold selective over MCT2. Phase 1.
Targets
MCT1
In vitro
In lymphoma cell lines that preferentially express MCT1, AZD3965 potently inhibits lactate transport and cell growth. AZD3965 inhibits MCT1 activity in cells, and shows higher sensitivity in hypoxia. In H526, HGC27 cells and DMS114 cells, AZD3965 increases intracellular lactate and significantly reduces lactate uptake.
In vivo
In nonobese diabetic scid-γ mice bearing COR-L103 xenografts, AZD3965 (100 mg/kg, p.o.) reduces tumor growth and increased intratumor lactate. In mice bearing H526 tumors, AZD3965 (100 mg/kg, p.o.) causes increased lactate concentration, a reduction in growth and increased radiation sensitivity.
查看阿拉丁官網(wǎng)此產(chǎn)品相關(guān)對應(yīng)頁面:https://www.aladdin-e.com/zh_cn/A413743.html



| 成立日期 | 2009-03-16 (18年) | 注冊資本 | 14130.676萬人民幣 |
| 員工人數(shù) | 500人以上 | 年營業(yè)額 | ¥ 1億以上 |
| 主營行業(yè) | 生物化工,化學試劑 | 經(jīng)營模式 | 工廠,試劑 |
| 產(chǎn)品名稱 | 價格 | 公司名稱 | 報價日期 | |
|---|---|---|---|---|
| 詢價 |
VIP5年
|
湖北魏氏化學試劑股份有限公司
|
2026-07-21 | |
| 詢價 |
VIP5年
|
TargetMol中國(陶術(shù)生物)
|
2026-06-29 | |
| 詢價 |
VIP5年
|
湖北威德利化學試劑有限公司
|
2026-04-28 |